SciSparc Ltd. SEC filings SPRC
SciSparc Ltd. has 607 filings in SEC EDGAR's recent list, going back to Jul 18, 2014. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3/A | Amendment no. 1 to form f-3 | Aug 19, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 17, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 3, 2026 | — |
| S-8 | Employee stock plan registration | Jan 26, 2026 | — |
| 424B5 | Prospectus supplement | Jan 14, 2026 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Nov 28, 2025 | — |
| 424B3 | Prospectus | Nov 4, 2025 | — |
| F-3/A | Amendment no. 3 to form f-3 | Jul 22, 2025 | — |
| 424B3 | Prospectus | Jul 21, 2025 | — |
| F-4/A | Amendment no. 9 to form f-4 | Jul 8, 2025 | — |
| F-4/A | Amendment no. 8 to form f-4 | Jun 25, 2025 | — |
| F-3/A | Amendment no. 2 to form f-3 | Jun 18, 2025 | — |
| F-3/A | Amendment no. 1 to form f-3 | Jun 10, 2025 | — |
| F-4/A | Amendment no. 7 to form f-4 | Jun 10, 2025 | — |
| F-4/A | Amendment no. 6 to form f-4 | May 27, 2025 | — |
| F-4/A | Amendment no. 5 to form f-4 | May 14, 2025 | — |
| F-4/A | Amendment no. 4 to form f-4 | Apr 29, 2025 | — |
| S-8 | Employee stock plan registration | Apr 28, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 25, 2025 | — |
| F-4/A | Amendment no. 3 to form f-4 | Mar 11, 2025 | — |
| F-4/A | Amendment no. 2 to form f-4 | Feb 13, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Jan 21, 2025 | — |
| F-4/A | Amendment no. 1 to form f-4 | Dec 31, 2024 | — |
| F-4 | Registration statement | Sep 26, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Aug 28, 2024 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Jun 17, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | May 2, 2024 | — |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Feb 27, 2024 | — |
| F-3/A | Amendment no. 1 to form f-1 | Nov 20, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 3, 2023 | — |
| 424B5 | Prospectus supplement | Aug 14, 2023 | — |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| 424B3 | Prospectus | Aug 9, 2023 | — |
| 424B5 | Prospectus supplement | May 16, 2023 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 on form f-3 | Mar 9, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 17, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 7, 2022 | — |
| POS AM | Post-effective amendment no.3 to form f-1 | Apr 28, 2022 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Oct 8, 2021 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Aug 27, 2021 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Aug 27, 2021 | — |
| 424B3 | Prospectus | Aug 9, 2021 | — |
| F-6 POS | Filing | Jul 26, 2021 | — |
| F-1/A | Amendment no. 1 to form f-1 | Apr 28, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Apr 21, 2021 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 31, 2021 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 31, 2021 | — |
| 424B3 | Prospectus | Feb 3, 2021 | — |
| 424B4 | Prospectus | Nov 20, 2020 | — |
| F-1MEF | Registration statement | Nov 19, 2020 | — |
| FWP | Free writing prospectus | Nov 5, 2020 | — |
| F-1/A | Amendment no. 3 to form f-1 | Nov 4, 2020 | — |
| FWP | Free writing prospectus | Oct 21, 2020 | — |
| F-1/A | Amendment no. 2 to form f-1 | Oct 21, 2020 | — |
| 424B3 | Prospectus | Oct 13, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Oct 9, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Sep 8, 2020 | — |
| 424B4 | Prospectus | Apr 2, 2020 | — |
| F-1/A | Amendment no. 4 to form f-1 | Mar 31, 2020 | — |
| F-1/A | Amendment no. 3 to form f-1 | Mar 30, 2020 | — |
| F-1/A | Amendment no. 2 to registration statement | Mar 26, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Mar 19, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jan 31, 2020 | — |
| 424B5 | Prospectus supplement | Dec 5, 2019 | — |
| F-3/A | Amendment no. 1 to form f-3 | Aug 29, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 22, 2019 | — |
| 424B5 | Prospectus supplement | Apr 1, 2019 | — |
| 424B2 | Prospectus | Aug 9, 2018 | — |
| F-3/A | Amendment to form f-3 | Jul 17, 2018 | — |
| S-8 | Employee stock plan registration | Jun 21, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 20, 2018 | — |
| 424B4 | Prospectus | Mar 22, 2017 | — |
| FWP | Free writing prospectus | Mar 20, 2017 | — |
| F-1/A | Amendment no. 8 to form f-1 | Mar 20, 2017 | — |
| F-1/A | Amendment no. 7 to form f-1 | Mar 15, 2017 | — |
| F-1/A | Amendment no.6 to form f-1 | Mar 3, 2017 | — |
| F-1/A | Amendment no.5 to form f-1 | Dec 20, 2016 | — |
| F-1/A | Amendment no. 4 to form f-1 | Dec 15, 2016 | — |
| F-1/A | Amendment no. 3 to form f-1 | Dec 14, 2016 | — |
| F-6 POS | Post effective amendment no. 1 to the form f-6 | Dec 7, 2016 | — |
| FWP | Free writing prospectus | Dec 6, 2016 | — |
| F-1/A | Amendment no. 2 to form f-1 | Dec 6, 2016 | — |
| 424B3 | Prospectus | Dec 5, 2016 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 23, 2016 | — |
| F-1 | Registration statement (foreign issuer) | Nov 4, 2016 | — |
| F-6 | Form f-6 | Jul 18, 2014 | — |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1611746
- Former names
- SciSparc Ltd./ADR (until Aug 27, 2021); Therapix Biosciences Ltd. (until Jan 28, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.